BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 37452933)

  • 1. Malignant Glioma.
    Wang LM; Englander ZK; Miller ML; Bruce JN
    Adv Exp Med Biol; 2023; 1405():1-30. PubMed ID: 37452933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benign Glioma.
    Wu PB; Filley AC; Miller ML; Bruce JN
    Adv Exp Med Biol; 2023; 1405():31-71. PubMed ID: 37452934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Classification of Diffuse Gliomas.
    Kalidindi N; Or R; Babak S; Mason W
    Can J Neurol Sci; 2020 Jul; 47(4):464-473. PubMed ID: 31918786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant glioma: should chemotherapy be overthrown by experimental treatments?
    Hösli P; Sappino AP; de Tribolet N; Dietrich PY
    Ann Oncol; 1998 Jun; 9(6):589-600. PubMed ID: 9681071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment modalities for malignant gliomas with reference to their pathophysiology].
    Kobayashi S; Takakura K
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):11-7. PubMed ID: 3942392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant gliomas.
    Burton EC; Prados MD
    Curr Treat Options Oncol; 2000 Dec; 1(5):459-68. PubMed ID: 12057153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
    Juratli TA; Schackert G; Krex D
    Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and genetic pathways in gliomas: the future of personalized therapeutics.
    Grant R; Kolb L; Moliterno J
    CNS Oncol; 2014 Mar; 3(2):123-36. PubMed ID: 25055018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances in the Treatment of Gliomas - Comprehensive Brain Tumor Center.
    Toms SA; Tapinos N
    R I Med J (2013); 2017 Jun; 100(6):43-46. PubMed ID: 28564669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Basic principles of diagnosis and treatment of gliomas].
    Wirsching HG; Weiss T; Roth P; Weller M
    Nervenarzt; 2018 Jun; 89(6):692-698. PubMed ID: 29679127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant glioma.
    Wheeler LA; Manzanera AG; Bell SD; Cavaliere R; McGregor JM; Grecula JC; Newton HB; Lo SS; Badie B; Portnow J; Teh BS; Trask TW; Baskin DS; New PZ; Aguilar LK; Aguilar-Cordova E; Chiocca EA
    Neuro Oncol; 2016 Aug; 18(8):1137-45. PubMed ID: 26843484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.
    Lefranc F; Rynkowski M; DeWitte O; Kiss R
    Adv Tech Stand Neurosurg; 2009; 34():3-35. PubMed ID: 19368079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of the 2016 WHO classification in Japanese patients with gliomas.
    Iuchi T; Sugiyama T; Ohira M; Kageyama H; Yokoi S; Sakaida T; Hasegawa Y; Setoguchi T; Itami M
    Brain Tumor Pathol; 2018 Apr; 35(2):71-80. PubMed ID: 29470683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of gene-mediated cytotoxic immunotherapy with AdV-tk as adjuvant to surgery and radiation for pediatric malignant glioma and recurrent ependymoma.
    Kieran MW; Goumnerova L; Manley P; Chi SN; Marcus KJ; Manzanera AG; Polanco MLS; Guzik BW; Aguilar-Cordova E; Diaz-Montero CM; DiPatri AJ; Tomita T; Lulla R; Greenspan L; Aguilar LK; Goldman S
    Neuro Oncol; 2019 Mar; 21(4):537-546. PubMed ID: 30883662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Advances in adults' gliomas biology, imaging and treatment].
    Ducray F; Dutertre G; Ricard D; Gontier E; Idbaih A; Massard C
    Bull Cancer; 2010 Jan; 97(1):17-36. PubMed ID: 20028650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaplastic Glioma: Treatment Approaches in the Era of Molecular Diagnostics.
    Ruff MW; Uhm J
    Curr Treat Options Oncol; 2018 Oct; 19(12):61. PubMed ID: 30361986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic decision making in patients with newly diagnosed low grade glioma.
    Tandon A; Schiff D
    Curr Treat Options Oncol; 2014 Dec; 15(4):529-38. PubMed ID: 25139406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Molecular Diagnostics in the Management of Patients with Gliomas.
    Wirsching HG; Weller M
    Curr Treat Options Oncol; 2016 Oct; 17(10):51. PubMed ID: 27501915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pattern of care of high-grade gliomas].
    Laigle-Donadey F; Sanson M
    Rev Prat; 2006 Oct; 56(16):1779-86. PubMed ID: 17315503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular features and clinical outcomes in surgically treated low-grade diffuse gliomas in patients over the age of 60.
    Morshed RA; Han SJ; Hervey-Jumper SL; Pekmezci M; Troncon I; Chang SM; Butowski NA; Berger MS
    J Neurooncol; 2019 Jan; 141(2):383-391. PubMed ID: 30498891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.